Nordén and Burke et al. found that valsartan reduces cardiac fibrosis during left ventricular pressure overload by restoring protein kinase G (PKG) signaling in cardiac fibroblasts, and they reported that valsartan improves cardiac hypertrophy and preserves diastolic during cardiac pressure overload [32, 33]. Here, PRKG1 is linked to cardiac hypertrophy.